• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Blood transfusion; additional historical aspects. Part 2. The introduction of chemical anticoagulants; trials of 'Phosphate of soda'.

作者信息

Boulton F E

机构信息

NHS BT, Southampton, UK.

出版信息

Transfus Med. 2013 Dec;23(6):382-8. doi: 10.1111/tme.12074. Epub 2013 Sep 12.

DOI:10.1111/tme.12074
PMID:24024967
Abstract

The pioneers of transfusion medicine around the turn of the 19th into the 20th centuries struggled with the awkward propensity of shed blood to clot. This article, a companion to a previous one (Boulton, 2013, Submitted for publication), describes in more detail how they recognised a potential for chemical anticoagulants which led to the introduction for a short period of sodium phosphate to aid blood transfusion: these cases preceded the introduction of citrate (Mollison, 2000, British Journal of Haematology, 108, 13-18).

摘要

相似文献

1
Blood transfusion; additional historical aspects. Part 2. The introduction of chemical anticoagulants; trials of 'Phosphate of soda'.
Transfus Med. 2013 Dec;23(6):382-8. doi: 10.1111/tme.12074. Epub 2013 Sep 12.
2
Blood transfusion; additional historical aspects. Part 1. The birth of transfusion immunology.
Transfus Med. 2013 Dec;23(6):375-81. doi: 10.1111/tme.12075. Epub 2013 Sep 4.
3
The use of citrate as an anticoagulant: the Southern connection.枸橼酸盐作为抗凝剂的应用:南方的关联。
Vox Sang. 1985;49(6):418-21. doi: 10.1111/j.1423-0410.1985.tb01134.x.
4
[The development of transfusion medicine (author's transl)].[输血医学的发展(作者译)]
MMW Munch Med Wochenschr. 1979 Nov 9;121(45):1485-8.
5
[The "Age" of anticoagulating materials in transfusion devices in the German speaking area].[德语区输血装置中抗凝材料的“使用期限”]
Anasthesiol Intensivmed Notfallmed Schmerzther. 2001 Nov;36 Suppl 2:S87-90. doi: 10.1055/s-2001-18195.
6
The introduction of citrate as an anticoagulant for transfusion and of glucose as a red cell preservative.枸橼酸盐作为输血抗凝剂以及葡萄糖作为红细胞保存剂的引入。
Br J Haematol. 2000 Jan;108(1):13-8. doi: 10.1046/j.1365-2141.2000.01827.x.
7
[Extracorporeal Circulation; Historical aspects; Part II].[体外循环;历史回顾;第二部分]
Thorac Cardiovasc Surg. 2008 Feb;56(1):1-8. doi: 10.1055/s-2007-965639.
8
The development and acceptance of the anticoagulant, CPD.抗凝剂枸橼酸磷酸盐葡萄糖(CPD)的研发与应用
Vox Sang. 1985;48(2):122-5. doi: 10.1111/j.1423-0410.1985.tb00156.x.
9
Transfusion medicine history illustrated: A historic picture: the first transfusion of citrated blood.输血医学历史图说:一幅历史图片:首次输注枸橼酸盐血。
Transfusion. 2011 Jun;51(6):1140-1. doi: 10.1111/j.1537-2995.2011.03087.x.
10
The history of blood transfusion prior to the 20th century--part 2.20世纪以前的输血史——第二部分。
Transfus Med. 2012 Dec;22(6):372-6. doi: 10.1111/j.1365-3148.2012.01189.x. Epub 2012 Sep 28.

引用本文的文献

1
Homologous blood transfusion and doping: Where are we now?同源输血与兴奋剂问题:我们目前处于什么状况?
Drug Test Anal. 2024 Dec;16(12):1479-1486. doi: 10.1002/dta.3666. Epub 2024 Feb 25.
2
Transfusion thresholds: the need for a patient-centered approach in hematologic disorders that require chronic transfusion therapy.输血阈值:在需要长期输血治疗的血液系统疾病中采用以患者为中心方法的必要性。
Blood Res. 2023 Apr 30;58(S1):S8-S10. doi: 10.5045/br.2023.2023009. Epub 2023 Feb 27.